Dewina Consult Sdn Bhd Leads The Way In Innovative Registration Information INSPECT SYSTEM For Control & Monitoring Covid-19 Self-Test

Brahim’s Dewina Group of Companies, through its consulting arm Dewina Consult Sdn Bhd, has launched Inspect System, an innovative registration system for COVID-19 self-test information that can be used by employers and organisations to facilitate better monitoring and control.  The objective of implementing the system is to encourage the community to conduct COVID-19 self-testing periodically and register information easily and systematically. Group Executive Chairman Dato’ Seri Ibrahim Ahmad said the system is the first in the Malaysian market that issues digital certificates after self-testing and is intended to complement the MySejahtera system.

The system is only applicable with the Newgene Bioengineering COVID-19 Antigen Detection Kit from Dewina Consult.  The kit is also equipped with Dewina QR and confirmation codes. The test results stated in the digital certificates are valid for three days.

Dewina Consult is the authorised importer and distributor for Newgene Bioengineering COVID-19 Antigen Detection Kit in Malaysia.

Dewina Consult has signed MoU with eMedAsia Sdn Bhd, a joint effort with the Malaysian Medical Association (via its investment arm Koop MAA) and HS Bio Sdn Bhd, to digitalise primary healthcare services in Malaysia.

The synergy with eMedAsia can help promote the Newgene Bioengineering COVID-19 Antigen Detection Kit with Inspect System to be made available through eMedAsia’s platform, especially for Koop MMA’s 8,000 member clinics and customers nationwide.